HOME › Press Releases › Flow Cytometry Market worth 4.93 Billion USD by 2021
Flow Cytometry Market worth 4.93 Billion USD by 2021
The report "Flow Cytometry Market by Technology (Cell & Bead-Based), Products (Analyzer, Sorter, Reagents & Consumables & Software), Application (Research & Clinical) & End User (Commercial Organization, Hospital & Clinical Testing Labs) - Global Forecasts to 2021", The flow cytometry market is expected to reach USD 4.93 Billion by 2021 from USD 3.14 Billion in 2016, at a CAGR of 9.4% between 2016 and 2021.
Browse 106 market data Tables and 35 Figures spread through 185 Pages and in-depth TOC on "Flow Cytometry Market by Technology (Cell & Bead-Based), Products (Analyzer, Sorter, Reagents & Consumables & Software), Application (Research & Clinical) & End User (Commercial Organization, Hospital & Clinical Testing Labs) - Global Forecasts to 2021"
Early buyers will receive 10% customization on reports.
Technological advancements in flow cytometry instruments, increasing use of flow cytometry in clinical trials, launch of new reagents for specific applications like diagnostics & drug discovery, development of user-friendly & intuitive software, growing prevalence of cancer & HIV/AIDS, and growing adoption of flow cytometry techniques in research activities will majorly drive the flow cytometry market.
This report broadly segments the global flow cytometry market on the basis of products & services, technologies, applications, and end users. The flow cytometry market, by products & services, is segmented into reagents & consumables, flow cytometry instruments, services, software, and accessories. The flow cytometry instruments segment is further categorized into cell analyzers and cell sorters.
On the basis of technology, the global flow cytometry market is segmented into cell-based flow cytometry and bead-based flow cytometry. In 2016, the cell-based flow cytometry technology is expected to account for the largest share of the global flow cytometry market, by technology.
Based on application, the global flow cytometry market is segmented into research applications, clinical applications, and industrial applications. In 2016, the research applications segment is expected to account for the largest share of the flow cytometry market, by application. The research applications segment is further subsegmented into pharmaceutical & biotechnology (drug discovery, in vitro toxicity testing, & stem cell research), apoptosis, immunology, cell cycle analysis, cell sorting, and cell viability. The clinical applications segment is further categorized into cancer, immunodeficiency diseases, hematology, and organ transplantation.
The end users of flow cytometry market include commercial organizations, hospitals, academic institutions & medical schools, clinical testing labs, and research institutes. In 2016, the commercial organizations end-user segment is expected to account for the largest share of the flow cytometry market, by end user.
This report covers the flow cytometry market across four major geographies, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America is expected to hold the largest share of this market in 2016, while Asia-Pacific is expected to grow at the highest rate during the forecast period from 2016 to 2021. Improving healthcare infrastructure, favorable government initiatives in Asia-Pacific region, and growing focus of market players on the Asia-Pacific flow cytometry market is expected to drive the flow cytometry market in this region.
Becton, Dickinson and Company (U.S.), Beckman Coulter, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Merck KGaA (Germany), Sysmex Partec GmbH (Germany), Luminex Corporation (U.S.), Miltenyi Biotec GmbH (Germany), Bio-Rad Laboratories, Inc. (U.S.), and Sony Biotechnology (U.S.) are the key players in the global flow cytometry market.
MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India